-+ 0.00%
-+ 0.00%
-+ 0.00%

NRx Pharmaceuticals plans underwritten public offering of common stock

PUBT·06/02/2026 20:02:34
Listen to the news
NRx Pharmaceuticals plans underwritten public offering of common stock
  • NRX Pharmaceuticals launched an underwritten follow-on offering of common stock; deal size, pricing, timing not disclosed.
  • Underwriters hold a 30-day option to buy up to 15% more shares on the same terms.
  • Net proceeds earmarked for working capital, general corporate purposes, growth support.
  • BTIG acting as lead bookrunner; Lucid Capital Markets serving as joint bookrunning manager.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NRX Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606021601PRIMZONEFULLFEED9730757) on June 02, 2026, and is solely responsible for the information contained therein.